Lead sponsor
Nxera Pharma UK Limited
5 Alzheimer’s disease and related dementias trials led. Source: ClinicalTrials.gov, as of July 21, 2026.
5
Trials led
0
Ongoing
236
Total enrollment
10
Sites
Distinct sites across this sponsor's lead trials. A site running several of them counts once, matching the map. Total enrollment sums each trial's reported enrollment, whether planned or actual.
Portfolio
How this sponsor's trials break down
Trials by phase
Phase 1
4
Phase 2
1
Trials by status
Completed
4
Withdrawn
1
Trials led
TrialEligibility highlightPhaseStatusEnrollment
Phase I, Healthy Subject, Safety, Tolerability and Pharmacokinetic Study of an M1 Agonist to Treat Cognitive ImpairmentHealthy volunteersPh 1Completed108
Multi-centre Study of HTL0018318 in Patients as an add-on to Standard-of-careAlzheimer's diseasePh 1Completed60
Phase 1 Study Investigating Effects of HTL0009936 on Cognition and BOLD fMRI Signals in Healthy Elderly SubjectsMMSE ≥24Ph 1Completed54